CAPS Medical

medical devices

About

CAPS Medical is a medical device company focused on developing and commercializing a minimally invasive cancer treatment technology using Cold Atmospheric Plasma (CAP). Their flagship product, PlasmaSure™, is designed to selectively ablate solid tumors while preserving surrounding healthy tissue. This approach aims to reduce the side effects and damage often associated with traditional cancer therapies. The company originated from collaborative research between the Technion’s Plasma Lab and Rambam Medical Center’s Cancer Lab in Israel. CAPS Medical targets a significant oncology therapeutics market, addressing the global health challenge posed by cancer, which results in millions of deaths and new diagnoses each year. Their technology is applicable to various cancer types, including lung, liver, breast, gastrointestinal, bladder, and prostate cancers. Led by CEO and Co-Founder Ilan Uchitel, CAPS Medical aims to serve oncologists, surgeons, and medical institutions seeking advanced, less invasive cancer therapies. Their innovative approach is designed to improve patient outcomes and reduce recovery times in cancer treatment.

Technologies

Outlook Amazon AWS Google Tag Manager Mobile Friendly Remote AI

Keywords

medical equipment manufacturing selective cancer cell targeting minimally invasive procedure surgery implantable devices r&d leadership clinical trials medical device development precision medicine cancer therapy b2b medical devices biotechnology electro-optical devices internal tumor treatment real-time energy control internal tumors regulatory affairs oncology cancer cell destruction investigational device targeted therapy medical equipment and supplies manufacturing regulatory approval disposable medical tools clinical research healthcare technology non-thermal atmospheric plasma patient safety real-time energy monitoring

Location

18 המלאכה, Netanya, Center District, Israel, 4250553

Related Companies

Companies in the same industry